KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Asset Writedowns and Impairment (2018 - 2025)

Historic Asset Writedowns and Impairment for National Health Investors (NHI) over the last 12 years, with Q3 2025 value amounting to -$2.0 million.

  • National Health Investors' Asset Writedowns and Impairment fell 15762.96% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 16289.59%. This contributed to the annual value of $5.3 million for FY2024, which is 28481.1% up from last year.
  • According to the latest figures from Q3 2025, National Health Investors' Asset Writedowns and Impairment is -$2.0 million, which was down 15762.96% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, National Health Investors' Asset Writedowns and Impairment ranged from a high of $29.2 million in Q4 2021 and a low of -$2.0 million during Q3 2025
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $1.1 million (2024), whereas its average is $6.2 million.
  • In the last 5 years, National Health Investors' Asset Writedowns and Impairment soared by 26528181.82% in 2021 and then tumbled by 24000.0% in 2025.
  • Quarter analysis of 5 years shows National Health Investors' Asset Writedowns and Impairment stood at $29.2 million in 2021, then decreased by 24.72% to $22.0 million in 2022, then crashed by 101.6% to -$351000.0 in 2023, then skyrocketed by 312.25% to $745000.0 in 2024, then tumbled by 365.64% to -$2.0 million in 2025.
  • Its Asset Writedowns and Impairment was -$2.0 million in Q3 2025, compared to -$1.4 million in Q2 2025 and -$14000.0 in Q1 2025.